D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea · Delayed Price · Currency is KRW 60,900
-4,800 (-7.31%)
Aug 11, 2026, 3:30 PM KST
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 2.79 trillion as of August 11, 2026. Its market cap has increased by 89.83% in one year.
Market Cap
2.79T
Enterprise Value
2.77T
Revenue
3.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
60,900.00
ChartMarket Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 2.79T, an increase of 635.46%. That is a compound annual growth rate of 140.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 2.79T | -30.15% |
| Dec 30, 2025 | 4.00T | 678.13% |
| Dec 30, 2024 | 513.61B | 35.32% |
| May 2, 2024 | 379.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SK Biopharmaceuticals | 6.69T |
| HLB Co., Ltd. | 4.96T |
| ABL Bio | 4.85T |
| Peptron | 4.24T |
| LigaChem Biosciences | 4.17T |
| Hugel | 2.95T |
| SK bioscience | 2.89T |
| Voronoi | 2.66T |